首页> 外文期刊>Oncology and Therapy >The Perspectives of Haematological Cancer Patients on Tissue Banking
【24h】

The Perspectives of Haematological Cancer Patients on Tissue Banking

机译:血液癌症患者对组织库的看法

获取原文
       

摘要

Background A high level of support for tissue banking has been identified amongst both the general public and patients. However, much debate remains about the regulatory framework of tissue banks. Objective This study explored the views of haematological cancer patients regarding tissue banking and how tissue banks should operate. Methods Haematological cancer patients from three outpatient clinics in Australia completed a questionnaire examining their preferences for tissue banking as well as items about their sociodemographic characteristics, disease and treatment history. Results The majority of participants (95%) reported being willing to allow their leftover tissue to be used for medical research. Three quarters (76%) supported the idea of their medical record being linked to their tissue sample, and 77% preferred a blanket (one-off) consent model for future research use of their tissue sample. Only 57 (27%) participants had been asked to give a tissue sample for research, 98% of whom gave permission. Conclusion The majority of haematological cancer patients are willing to donate their leftover tissue to a tissue bank and have their medical records linked to tissue samples and prefer a one-off consent process. These novel data from potential donors inform the debate about how tissue banks might operate. Funding Strategic Research Partnership Grant from the Cancer Council NSW to the Newcastle Cancer Control Collaborative (New-3C) and infrastructure funding from the Hunter Medical Research Institute (HMRI). A.W. is supported by an Australian Research Council DECRA fellowship (DE150101262). T.C.M. was supported by a Leukaemia Foundation of Queensland Post-Doctoral Fellowship. A.B. is supported by National Health and Medical Research Council (APP1073317) and Cancer Institute NSW (13/ECF/1–37) Early Career Fellowships.
机译:背景技术已经在公众和患者中确定了对组织银行业务的高水平支持。但是,关于组织库的监管框架仍存在许多争论。目的本研究探讨了血液肿瘤患者关于组织库和组织库应如何操作的观点。方法来自澳大利亚三个门诊的血液癌症患者填写了一份调查表,检查了他们对组织保存的偏好以及有关其社会人口统计学特征,疾病和治疗史的项目。结果大多数参与者(95%)报告愿意将其剩余的组织用于医学研究。四分之三(76%)的人支持将他们的病历与组织样本联系起来的想法,而77%的人更喜欢一揽子(一次性)同意模型,以便将来对其组织样本进行研究。仅要求57位(27%)参与者提供组织样本进行研究,其中98%的参与者同意。结论大多数血液癌症患者愿意将剩余的组织捐献给组织库,并把他们的病历与组织样本联系起来,并且倾向于一次性的同意程序。来自潜在捐赠者的这些新颖数据为有关组织库如何运作的争论提供了信息。新南威尔士州癌症委员会向纽卡斯尔癌症控制合作组织(New-3C)提供的战略研究合作伙伴资金以及亨特医学研究所(HMRI)的基础设施资金。 A.W.由澳大利亚研究委员会DECRA奖学金(DE150101262)支持。 T.C.M.得到昆士兰大学博士后奖学金基金会的支持。 A.B.由国家卫生与医学研究委员会(APP1073317)和新南威尔士州癌症研究所(13 / ECF / 1–37)的早期研究金支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号